HIPAA Compliance for Liver Disease Treatment Records: What Providers and Patients Need to Know

Understanding the HIPAA Privacy Rule

What counts as Protected Health Information

Protected Health Information (PHI) covers any individually identifiable health data in any form—paper, oral, or electronic. For liver disease, that includes lab values (ALT/AST, bilirubin, INR, MELD score), imaging, biopsy results, transplant evaluations, medication lists, portal messages, and care plans tied to a patient.

Permitted uses and disclosures

You may use and disclose PHI without patient authorization for treatment, payment, and health care operations. Sharing hepatology notes with a transplant center, exchanging labs with a primary care physician, or coordinating antiviral therapy are all permissible for treatment. Disclosures beyond those purposes generally require written authorization.

Minimum necessary and safeguards

Apply the minimum necessary standard to payment and operations, limiting access to just what staff need. Implement role-based access, audit logs, and encryption for ePHI. The minimum necessary rule does not restrict disclosures for treatment or a patient’s own access requests.

Electronic Health Information and interoperability

Electronic Health Information (EHI) refers to electronic PHI in a Designated Record Set. HIPAA sets the baseline for privacy and security, while interoperability rules aim to remove unnecessary barriers to accessing and exchanging EHI. Keep policies aligned so your HIPAA procedures do not inadvertently create Information Blocking risks as regulations evolve toward the Compliance Deadline 2026.

Defining the Designated Record Set

What is included

The Designated Record Set (DRS) contains records you maintain that are used to make decisions about an individual. For liver disease treatment, that typically includes clinic notes, consults, lab and imaging results, pathology, medication histories, problem lists, transplant workups, external records relied upon for care, and billing and enrollment records.

What is excluded

Excluded items often include psychotherapy notes, clinician working notes kept separately for personal use, quality improvement files, peer review materials, and data not used to make decisions about the patient. Duplicate copies and de-identified datasets are also outside the DRS.

Operationalize your DRS

Map which EHR modules, imaging systems, and ancillary platforms hold DRS content. Document sources of scanned outside records used for decision-making. Maintain a simple inventory so staff can reliably fulfill access requests that span your enterprise content, not just the primary EHR.

Exercising Patient Access Rights

Timelines and formats

Patients have a right to access PHI in the DRS. Provide records within 30 days, with one 30‑day extension if necessary and explained in writing. Supply records in the form and format requested if readily producible; otherwise offer a mutually agreeable alternative (for example, PDF, portal download, or readable CD/USB).

Reasonable, cost-based fees

You may charge only reasonable, cost-based fees for copying and fulfilling requests, covering labor for duplication, supplies, and postage. Never condition access on in-person pickup or on the requester using a particular portal or app.

Directed access and apps

Patients can direct you to send records to a designated third party. For electronic requests, support API-enabled access when available, recognizing that EHI commonly spans data beyond a narrow summary. Verify identities reasonably without creating barriers.

Denials and patient safety

Limited, reviewable denials may apply when releasing information would likely endanger life or physical safety. Excluded categories (such as psychotherapy notes) may be denied without review. When denying any portion, release the remainder and explain appeal options where applicable.

Managing Substance Use Disorder Records

When 42 CFR Part 2 applies

42 CFR Part 2 adds protections for records from federally assisted programs that diagnose, treat, or refer for substance use disorders. In liver care, this commonly arises when coordinating treatment for alcohol-associated liver disease or hepatitis C with addiction services.

Patient Consent Requirements and redisclosure

Part 2 generally requires specific, written patient consent before disclosing SUD records outside permitted purposes. Disclose only what the consent authorizes, and include the required Part 2 notice against unauthorized redisclosure. Train staff to recognize and properly segment SUD content in mixed hepatology records.

Practical steps for mixed hepatology/SUD care

• Tag Part 2 documents in your EHR and use data segmentation so non-Part 2 disclosures do not inadvertently include protected SUD notes.
• Use tailored consent forms that specify recipients, purpose, and scope when sharing with transplant centers or payers.
• Coordinate with billing so claim details do not reveal SUD diagnoses unless allowed by consent.

Aligning with the Compliance Deadline 2026

Part 2 has been updated to better align with HIPAA. Review your privacy notices, consent templates, disclosure logs, and breach-response plans to meet the Compliance Deadline 2026. Prioritize staff training so hepatology teams understand how Part 2 requirements intersect with routine HIPAA workflows.

Ensuring Compliance with Information Blocking Prohibitions

What Information Blocking covers

Information Blocking occurs when an actor (such as a health care provider) knowingly interferes with access, exchange, or use of EHI. EHI is electronic PHI in a Designated Record Set, not just a narrow data subset. HIPAA compliance alone is not enough—your processes must also avoid practices that unreasonably delay or restrict data sharing.

Common pitfalls for liver clinics

• Delaying release of normal labs or imaging until a clinician reviews them without a patient safety justification.
• Refusing to send results to a patient-chosen app when technically feasible.
• Charging impermissible fees, or requiring proprietary forms when a valid request already exists.

Recognized exceptions

Certain exceptions allow you to limit or delay sharing, including preventing harm, protecting privacy, ensuring security, addressing infeasibility, and meeting content-and-manner constraints. Document your rationale and apply exceptions narrowly and consistently.

Preparing for audits and 2026 horizons

Publish clear release-of-information policies, monitor turnaround times, and test API connections to ensure patient-directed exchange works. Align HIPAA right-of-access workflows with Information Blocking requirements and update them as enforcement expands toward the Compliance Deadline 2026.

Handling Billing and Payment Records

What billing PHI includes

Billing and payment files are part of the DRS when used to make decisions about the individual. In hepatology, that often includes claims, remittances, prior authorizations for antivirals or transplant evaluations, coding (ICD-10/CPT), and explanations of benefits tied to a specific patient.

Access and disclosures

Patients may request copies of billing and payment information and receive them within standard timelines. For disclosures, apply the minimum necessary rule and restrict access to staff who need it for payment operations.

Special considerations

When SUD services are involved, 42 CFR Part 2 may require consent before disclosing billing details that reveal diagnosis or treatment. Patients who pay in full out-of-pocket may request restrictions on disclosures to health plans for that encounter; honor these requests when feasible.

Documentation and retention

Maintain clear records of what was released, to whom, and under which authority or consent. HIPAA sets retention requirements for policies and certain documentation, while medical-record retention periods are governed largely by state law—build your schedule accordingly.

Accessing Archived Treatment Records

Legacy systems and media

Archived liver disease records—scanned charts, retired EHRs, PACS archives, or offsite storage—remain part of the DRS if you use them to make decisions. Plan for retrieval so you can meet access deadlines even when data lives outside your active EHR.

Operational tips

• Maintain a record-locator index that spans current and legacy repositories, including imaging and transplant evaluation files.
• Test retrieval workflows quarterly and pre-stage high-demand archives (for example, serial ultrasounds or elastography).
• Provide readable copies; if the original format is proprietary, convert or export to a commonly usable form.

Conclusion

HIPAA sets the foundation for privacy and access, the Designated Record Set defines scope, 42 CFR Part 2 adds extra protection for SUD content, and Information Blocking rules push timely EHI exchange. By documenting your DRS, tightening release workflows, honoring patient consent requirements, and preparing for the Compliance Deadline 2026, you protect patients and streamline liver disease care.

FAQs

What records are included in the designated record set under HIPAA?

The designated record set includes records you maintain that are used to make decisions about a patient, such as clinic notes, consults, labs, imaging, pathology, medication lists, care plans, and billing or enrollment files. Materials like psychotherapy notes and purely administrative documents not used for clinical decisions are typically excluded.

How does 42 CFR Part 2 affect liver disease treatment records?

When a federally assisted SUD program is involved, 42 CFR Part 2 requires patient consent before disclosing substance use disorder records outside permitted purposes. In hepatology, segment and tag SUD-related notes so you can share liver-care information while honoring stricter Part 2 protections and the patient’s consent choices.

Can patients request copies of their billing and payment information?

Yes. Billing and payment records that relate to the individual are part of the designated record set, and patients may request copies. You must provide them within standard HIPAA timelines and may charge only reasonable, cost-based fees for fulfilling the request.

What are the consequences of information blocking under HIPAA?

Information Blocking is governed by the 21st Century Cures Act, not HIPAA, but the two regimes intersect. Interfering with access, exchange, or use of EHI can trigger federal enforcement and program disincentives, and it often signals problems with HIPAA right-of-access compliance. Align your policies to meet both sets of requirements.